The PIVATAL Study focuses on patients with a Left Ventricular Assist Device (LVAD), a machine that helps the heart pump blood. The study looks at whether a treatment called Ventricular Tachycardia Ablation (VTA ablation) can reduce irregular heartbeats called ventricular tachycardia (VTA) after LVAD surgery. Patients will be randomly assigned to either have VTA ablation during their LVAD surgery or receive standard medical care. The study will collect information on heart rhythm, treatments, and health care needs.
- The study involves 100 patients and lasts about 18 months.
- Participants need to have a history of VTA and be eligible for an LVAD.
- The study checks for additional procedures and health care visits.
To join, patients must be over 18, have certain heart conditions, and be able to give consent. They should not have already had successful VTA ablation without more VTA or be in other trials. The study helps understand how to better treat patients with heart support devices.